Aktie A2QB3X NOVACCESS GLOBAL INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen NovAccess Global Inc.

Aktien

A2QB3X

US67001N1072

XSNX

Verzögert OTC Markets
Andere Börsenplätze
 15:46:10 29.04.2024 		% 5 Tage % 1. Jan.
0,0055 USD +7,84 % Intraday Chart für NovAccess Global Inc. -21,43 % -72,64 %
27.02. NovAccess Global Inc. meldet Ergebnis für das erste Quartal bis zum 31. Dezember 2023 CI
09.02. NovAccess Global Inc. meldet Ergebnis für das am 30. September 2023 endende Gesamtjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
NovAccess Global Inc. announced that it has received $0.1 million in funding from AJB Capital Investments LLC
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
NovAccess Global Announces $10.7 Million Financing
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
NovAccess Global Inc. Appoints Roscoe M. Moore, Jr. to Scientific Advisory Board
NovAccess Global Inc. announced that it expects to receive $10.68 million in funding from Sumner Capital Pty Ltd.
NovAccess Global Inc. announced that it expects to receive $0.055 million in funding
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
NovAccess Global Inc. announced that it has received $0.055 million in funding from 1800 Diagonal Lending, LLC
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
NovAccess Global Inc. Enters into a Letter Agreement with AJB Capital Investments, LLC
NovAccess Global Inc. Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalised Healthcare Therapies
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QB3X Aktie
  4. Nachrichten NovAccess Global Inc.
  5. Andere Sprachen